1,25-Dihydroxyvitamin D₃ Suppresses the Expression of the VCAM-1 Receptor, VLA-4 in Human Leukemic HL-60 Cells

By Kaneko A.   Suzuki S.   Hara M.   Mori J-I.   Kumagai M.   Yajima H.   Yamashita K.   Kakizawa T.   Yamazaki M.   Takeda T.   Miyamoto T.   Ichikawa K.   Hashizume K.  

Biochemical and Biophysical Research Communications, Vol. 255, Iss. 2, 1999-02 ,pp. : 371-376

Elsevier

Access to resources Recommend Favorite

Mechanistic Studies to Evaluate the Enhanced Antiproliferation of Human Keratinocytes by 1α,25-Dihydroxyvitamin D₃–3-bromoacetate, a Covalent Modifier of Vitamin D Receptor, Compared to 1α,25-Dihydroxyvitamin D₃

By Chen M.L.   Ray S.   Swamy N.   Holick M.F.   Ray R.  

Archives of Biochemistry and Biophysics, Vol. 370, Iss. 1, 1999-10 ,pp. : 34-44

Elsevier

Access to resources Recommend Favorite

Antagonistic Action of Novel 1α,25-Dihydroxyvitamin D₃-26,23-Lactone Analogs on 25-Hydroxyvitamin-D₃-24-hydroxylase Gene Expression Induced by 1α,25-Dihydroxy-vitamin D₃ in Human Promyelocytic Leukemia (HL-60) Cells

By Ishizuka S.   Miura D.   Eguchi H.   Ozono K.   Chokki M.   Kamimura T.   Norman A.W.  

Archives of Biochemistry and Biophysics, Vol. 380, Iss. 1, 2000-08 ,pp. : 92-102

Elsevier

Access to resources Recommend Favorite

Regulation of renal vitamin D receptor is an important determinant of 1α,25-dihydroxyvitamin D₃ levels in vivo

By Beckman M.J.   DeLuca H.F.  

Archives of Biochemistry and Biophysics, Vol. 401, Iss. 1, 2002-05 ,pp. : 44-52

Elsevier

Access to resources Recommend Favorite

Expression of nephronectin is enhanced by 1α,25‐dihydroxyvitamin D₃

By  

FEBS Open Bio, Vol. 6, Iss. 9, 2016-09 ,pp. : 914-918

John Wiley & Sons Inc

Access to resources Recommend Favorite